Concepedia

A. Y. Bedikian

AY

11

Publications

580

Citations

11

H-Index

1981

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Oncology Specialists

A. Y. Bedikian is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1981–2010

11

Publications

11

Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.

Antônio C. Buzaid, Merrick I. Ross, Charles M. Balch et al. · Journal of Clinical Oncology · 1997 · 302 citations

Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.

Sewa S. Legha, Sigrid Ring, Omar Eton et al. · PubMed · 1997 · 64 citations

A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, ± dacarbazine (DTIC) in patients with metastatic melanoma (MM)

Peter Hersey, Jeff Sosman, Steven O’Day et al. · Journal of Clinical Oncology · 2005 · 55 citations

, , +17

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

Julie A. Ellerhorst, A. Y. Bedikian, Sigrid Ring et al. · Oncology Reports · 1999 · 49 citations

Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma

A. Y. Bedikian, Sewa S. Legha, Omar Eton et al. · Annals of Oncology · 1997 · 29 citations · Full text

, , +7

Rows per page

1–5 of 11